Free Trial
NASDAQ:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

Biotricity logo
$0.26 -0.03 (-9.69%)
(As of 12:31 PM ET)

About Biotricity Stock (NASDAQ:BTCY)

Key Stats

Today's Range
$0.25
$0.26
50-Day Range
$0.23
$0.57
52-Week Range
$0.19
$1.67
Volume
28,615 shs
Average Volume
76,045 shs
Market Capitalization
$6.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Stock News Headlines

H.C. Wainwright Reaffirms Their Hold Rating on Biotricity (BTCY)
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
Biotricity, Inc. (BTCY) Q2 2025 Earnings Call Transcript
See More Headlines

BTCY Stock Analysis - Frequently Asked Questions

Biotricity's stock was trading at $1.15 at the start of the year. Since then, BTCY shares have decreased by 77.0% and is now trading at $0.2649.
View the best growth stocks for 2024 here
.

Biotricity, Inc. (NASDAQ:BTCY) posted its quarterly earnings data on Thursday, June, 27th. The company reported ($0.47) earnings per share for the quarter, missing analysts' consensus estimates of ($0.36) by $0.11. The company earned $3.18 million during the quarter, compared to analyst estimates of $3.20 million.

Biotricity (BTCY) raised $15 million in an initial public offering on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include TransDigm Group (TDG), Taiwan Semiconductor Manufacturing (TSM), Wix.com (WIX), Datadog (DDOG), Quanta Services (PWR), PayPal (PYPL) and Royal Caribbean Cruises (RCL).

Company Calendar

Last Earnings
6/27/2024
Today
12/26/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BTCY
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Net Income
$-14,090,000.00
Pretax Margin
-97.04%

Debt

Sales & Book Value

Annual Sales
$12.06 million
Book Value
($3.34) per share

Miscellaneous

Free Float
22,075,000
Market Cap
$6.94 million
Optionable
Optionable
Beta
1.14
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:BTCY) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners